PA
PRAA icon

PharVision Advisers’s PRA Group PRAA Stock Holding History

PharVision Advisers’s Portfolio PRAA Stock Details PRAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,228
Closed -$255K – 468
2024
Q4 		$255K Buy
+12,228
New +$261K 0.22% 215

Other funds holding PRAA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return

PharVision Advisers's PRAA Position: Q1 2025 in Review

PharVision Advisers sold out of PRA Group (PRAA) in Q1 2025, closing a stake of 12,228 shares — an estimated $255K sold.

PharVision Advisers first reported a position in PRAA in Q4 2024 and held it in 1 quarter. The position peaked at $255K in Q4 2024. 197 funds tracked by Wall St. Rank hold PRAA as of Q1 2025.

  • PharVision Advisers reported no remaining PRA Group position as of Q1 2025 after selling out during the quarter.
  • PharVision Advisers sold 12,228 PRA Group shares in Q1 2025, an estimated $255K.
  • PharVision Advisers first reported a position in PRA Group in Q4 2024 and held it in 1 quarter.
  • PharVision Advisers's PRA Group position peaked at $255K in Q4 2024.
  • 197 funds tracked by Wall St. Rank held PRA Group as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.